Locations:
SearchExperienced team, innovative treatment
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/90ebbb11-aed8-4e27-91f8-ddfcdca03dd1/17-DDI-3877-Quintini-CQD-Hero_jpg)
17-DDI-3877-Quintini-CQD-Hero
By Cristiano Quintini, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A 42-year-old female was referred to our institution with large right colon cancer and synchronous bilobar liver metastasis (see presenting CT scan of the liver above). A particular challenge was presented by the lesion encasing the three hepatic veins of the liver (see arrows).
The patient received three months of perioperative chemotherapy and was scheduled (three months after the initial presentation) for a two-stage hepatectomy and a combined resection of the primary right colon tumor.
The first surgery included a right hemicolectomy with resection of all the left-sided liver lesions. The surgery was uneventful. On postoperative day 6, the patient underwent a right portal vein embolization with the intent to induce hypotrophy of the right hemi liver and the hypertrophy of the left hemi liver. This approach is used to decrease the risks of postresection liver failure.
Six weeks after the first operation, the patient underwent a right hepatectomy. Given her young age and the extent of the disease, the decision was made to place to also place a hepatic artery infusion (HAI) pump to further decrease her likelihood of recurrence. HAI locoregional treatment is an innovative approach that improves survival after liver resection for metastatic colon cancer. This treatment option is only delivered in selected centers around the world.
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/336ab2a6-d780-428c-bfa0-43a6027e8fe5/17-DDI-3877-Quintini-CQD-Inset1_jpg)
The remnant left liver lobe with a catheter inside the gastro-duodenal artery for HAI treatment.
One year after the initial presentation, the patient is free of tumor (see scan below) and receiving routine follow-up scans.
Advertisement
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/375db05f-5da2-45c9-9963-5600dbbcf5ee/17-DDI-3877-Quintini-CQD-Inset2_jpg)
CT scan showing the patient free of tumor.
Advertisement
Advertisement
Landmark trial data suggest appendectomy may reduce relapse and improve remission rates in select patients
Implications for surgical decision-making and patient management
Dr. Prabhu discusses mentorship, collaboration and her vision for the future of the department
New program looks to innovative approaches for advancing early detection and multicancer prevention
Patients have a significantly higher risk of developing fistulas and experiencing future Crohn’s-like changes
Cleveland Clinic researchers developed an objective tool to assess response following total neoadjuvant therapy.
Patients may benefit from booster appointments, psychological support
Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment